期刊文献+

生地提取物对肺间质纤维化大鼠肺系数及MCP-1 mRNA表达的影响 被引量:3

Influences of Shengdihuang(Rehmanniae recens Radix) Extract on Pulmonary Index and Monocyte Chemoattractant Protein-1 mRNA Expression of Pulmonary Interstitial Fibrosis Rats
原文传递
导出
摘要 目的检测生地提取物对肺间质纤维化模型大鼠肺系数及MCP-1 mRNA表达的影响并初步研究其作用产生的内在机理。方法博莱霉素气管内注入法复制大鼠肺间质纤维化模型。随机分为正常组、模型组、生地提取物组和甲强龙组,各组分别在造模后第3、7、28天处死总数的1/3只,取全肺称重,计算肺系数,并用逆转录多聚酶链反应(RT-PCR)方法,检测MCP-1 mRNA的表达。结果第28天生地提取物组和甲强龙组肺系数较模型组有减小趋势。MCP-1 mR-NA的表达在肺间质纤维化过程中增加,第7天时达到高峰,模型组MCP-1 mRNA的表达高于正常组(P <0. 05),第28天时已有回落。生地提取物组和甲强龙组第7天和第28天MCP-1 mRNA均有低于模型组的趋势。结论生地提取物可改善肺间质纤维化模型大鼠肺系数;生地提取物抑制肺间质纤维化过程中MCP-1mRNA的表达,从而可能延缓大鼠肺纤维化的形成。 Objective To investigate influences of Shengdihuang( Rehmanniae recens Radix) extract on pulmonary index and expression of monocyte chemoattractant protein-1( MCP-1) mRNA,for the preliminary study of the internal mechanism. Methods The model of pulmonary interstitial fibrosis in rats was reproduced by bleomycin endotracheal injection. They were randomly divided into the normal group,the model group,the Shengdihuang extract group and the methylprednisolone group. 8 rats in each group were sacrificed on the 3 rd,7 th and 28 th day after the intratracheal instillation. The weight and pulmonary index were counted. The mRNA of( MCP-1) was determined by reverse transcription-polymerase chain reaction( RT-PCR). Results On the 28 th day,the pulmonary index had a downward trend on the Shengdihuang extract group and the methylprednisolone group,compared to the model group. The expression of MCP-1 mRNA increased during pulmonary interstitial fibrosis,and peaked on the 7 th day. The expression of MCP-1 mRNA in the model group was higher than that in the normal group( P < 0. 05),and it fell back on the 28 th day. The trend of MCP-1 mRNA both in the Shengdihuang extract group and the methylprednisolone group was lower than the model group on the 7 th and 28 th day. Conclusion Shengdihuang extract can improve pulmonary index of the pulmonary fibrosis rats,and inhibit the expression of MCP-1 mRNA during pulmonary interstitial fibrosis,which may delay the formation of pulmonary fibrosis in rats.
作者 张兴 史苗颜 孙萌 张艺宝 张一乐 刘鲁炯 张炜 ZHANG Xing;SHI Miao-yan;SUN Meng;ZHANG Yi-bao;ZHANG Yi-le;LIU Lu-jiong;ZHANG Wei(Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China)
出处 《时珍国医国药》 CAS CSCD 北大核心 2018年第12期2884-2886,共3页 Lishizhen Medicine and Materia Medica Research
基金 上海市科委基金资助项目(16401930100) 上海中医临床重点实验室(14DZ2273200)
关键词 生地提取物 肺间质纤维化 大鼠 肺系数 单核细胞趋化蛋白-1 Shengdihuang extract Pulmonary interstitial fibrosis Rats Pulmonary index Monocyte chemoattractant protein-1
  • 相关文献

参考文献3

二级参考文献19

  • 1韩萍.特发性肺间质纤维化的中医治疗[J].青岛医药卫生,2004,36(2):115-115. 被引量:7
  • 2马慧,杜秀芳,姜向忠,王嘉祺.运动心肺功能试验对特发性肺纤维化早期诊断价值探讨[J].中国实用内科杂志,2004,24(11):672-673. 被引量:5
  • 3郑金旭,贾友明,许祖德,庄丽,刘广东,唐山娣.Ⅰ型和Ⅲ型胶原的测定对隐源性致纤维化性肺泡炎活动性诊断意义的探讨[J].上海医科大学学报,1993,20(3):192-196. 被引量:15
  • 4张炜.生地注射液防治大鼠肺间质纤维化的实验研究.第三届全国中西医结合实验医学学术研讨会论文集[M].,1999.83.
  • 5张炜.生地注射液对实验性大鼠肺纤维化的胶原代谢影响的实验研究[J].中华实用中西医杂志,1999,10(12):1706-1706.
  • 6陈灏珠,主编.实用内科学[M] 第12版.北京:人民卫生出版社,2005.1 579-1 582.
  • 7中华人民共和国卫生部.中药新药临床指导研究原则[M].北京:中国医学科技出版社,2002:54-58,80.
  • 8Tsai SL,Liaw YF,Lai CL,et al.Repatitis cvims variarls circumventing cytotoxic dympnoeyte tivity as a mecJhanism of clhronicity[J].Gas-troenterology,1998,115(4):954.
  • 9Anin S,Jiirgen B,Giinter F.Catdiorespiratory responses to inere-mental exercise in patients witlh systemic sclerosis[J].Chaest,1996,110(6):1520-1525.
  • 10沈映君.中药药理学[M].第2版.上海:上海科学技术出版社,2002:59-60.

共引文献47

同被引文献46

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部